By: Dr. Lucica Ditiu and Dr. Catharina Boehme The numbers speak for themselves. In 2015 alone: 1.8 million died from tuberculosis (TB); 10.4 million people fell ill with the disease; and An estimated 480,000 developed multidrug resistant-TB (MDR-TB). All of this, combined with the airborne transmission of the disease, makes TB the leading infectious disease killer (surpassing both HIV … Read More
Innovations in Global Health: Fio Market Solutions for Frontline Health Workers
A new series featuring promising product or service innovations in global health Fio is a global leader at the confluence of key forces reshaping healthcare: decentralization of care; mobile smart technology; big data aggregation; artificial intelligence; predictive analytics and insight; performance-based funding; and globally affordable, inclusive solutions. Fio innovated and globally markets a solution, Fionet, consisting of AI-powered, hand-held smart-devices, … Read More
PSD Elects Board Member and Alternate to Global Fund Board
Members of the PSD Advisory Group elected Julie Essiam (CEO, Ecobank Foundation & Group Executive, Human Resources and Corporate Affairs, Ecobank Transnational Incorporated) to her first term as Board Member. Ms. Essiam replaces Paul Schaper (Executive Director, Global Public Policy, Merck, Sharp & Dohme), who served in the role for two terms from 2013-2017. Mr. Schaper has been elected as … Read More
Event Takeaways | World Malaria Day 2017 Stakeholders Meeting
Friday, 28 April 2017 10:30 AM – 12:30 PM WAT On the occasion of World Malaria Day 2017, the Corporate Alliance on Malaria in Africa (CAMA) convened more than 60 business executives and corporate health managers, along with technical experts, government officials and program implementers, for a stakeholders meeting hosted by ExxonMobil in Lagos, Nigeria. The meeting offered participants a … Read More
CAMA Releases New Report: Mobilizing Nigeria’s Private Sector for Malaria Control & Elimination
On the occasion of World Malaria Day 2017, the Corporate Alliance on Malaria in Africa (CAMA) convened more than 60 business executives and corporate health managers, along with technical experts, government officials and program implementers. As part of this meeting, CAMA launched a new report entitled: Mobilizing Nigeria’s Private Sector for Malaria Control & Elimination. The report provides insights for … Read More
#GBCtalksmalaria with Julie Essiam, Ecobank
This interview is part of a series in which experts discuss key aspects of the malaria challenge– innovation, program implementation, finance and policy. We hope the series sparks conversation and encourages others to determine how they can best contribute to the fight to end malaria for good. Follow the conversation on twitter using #GBCtalksmalaria In your opinion, what would be some positive game … Read More
#GBCtalksmalaria with Herbert Schilthuis, Heineken
This interview is part of a series in which experts discuss key aspects of the malaria issue – innovation, program implementation, finance and policy. We hope the series sparks conversation and encourages others to determine how they can best contribute to the fight to end malaria for good. Follow the conversation on twitter using #GBCtalksmalaria In your opinion what would be some positive … Read More
Key Upcoming GBCHealth Events
World Malaria Day Stakeholder’s Meeting April 28, 2017 10.00-12.30 WAT St. Victoria Island, Lagos, Nigeria Organized by: Corporate Alliance on Malaria in Africa (CAMA) World Malaria Day offers an annual opportunity to highlight advances in malaria prevention and control and to commit to continued investment and action to accelerate progress against this deadly disease. This year’s theme “End Malaria for … Read More
Innovations in Global Health: Kinnos, Inc. and Highlight
“Innovations in Global Health” is a new series featuring promising product or service innovations in global health Kinnos Inc. is a New York-based company that’s raising the standard of infectious disease decontamination to protect healthcare workers, patients, and the general public. Their first product, Highlight, is a patent-pending additive that greatly improves visibility, coverage, and end-user compliance of disinfectants. Highlight … Read More
#GBCtalksmalaria with Jon Pender, GSK
This interview is part of a series in which experts discuss key aspects of the malaria challenge– innovation, program implementation, finance and policy. We hope the series sparks conversation and encourages others to determine how they can best contribute to the fight to end malaria for good. Follow the conversation on twitter using #GBCtalksmalaria In your opinion, what would be positive game changers … Read More